Prawo i regulacje · 24/01/2020

Brexanolone Schedules Classified as Controlled Substance

The Drug Enforcement Administration has finalized a rule placing brexanolone, a medication used to treat anxiety, under the Controlled Substances Act, maintaining its classification as a Schedule IV controlled substance, as previously established in 2019.